BioSpace News Archive

Biotech Bay

Aimmune Eyes 2020 Approval of Peanut Allergy Treatment

Aimmune’s peanut allergy treatment is one-step closer to approval following strong support from the Allergenic Products Advisory Committee, which overwhelmingly recommended approval of Palforzia, the proposed trade name of the investigational oral treatment, AR101.

September 19, 2019
·
3 min read
·
Alex Keown
Employer Resources

4 Ways Employee Recognition Can Decrease Turnover

The amount of recognition workers receive can be linked to employee turnover rates.

September 19, 2019
·
3 min read
·
Porschia Parker
BioMidwest

Research Roundup: Alzheimer’s Memory Loss Reversed and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

September 19, 2019
·
5 min read
·
Mark Terry
Researchers Develop New Class of Lung Cancer Drugs

Working with a new class of cancer drugs called G12C KRAS inhibitors, researchers at the Francis Crick Institute and The Institute of Cancer Research (ICR), London, developed drug combinations to stay ahead of drug resistant tumors.

September 19, 2019
·
2 min read
·
Mark Terry
Business

Speaker Pelosi Unveils Plan to Negotiate Lower Drug Prices

House Speaker Nancy Pelosi unveiled her plan to lower the prices on up to 250 prescription drugs covered by government-backed plans such as Medicare.

September 19, 2019
·
2 min read
·
Alex Keown
Drug Development

Novartis Releases Interim Data from Zolgensma Trial

AveXis presented new interim data from the Phase III SPR1NT trial of Zolgensma (onasemnogene abeparvovec-xioi) in spinal muscular atrophy (SMA) Type 1.

September 19, 2019
·
4 min read
·
Mark Terry
BioCapital

BioSpace Movers & Shakers, Sept. 20

Biotech and pharma companies from across the globe strengthen their leadership teams and boards of directors with this week’s appointments.

September 19, 2019
·
6 min read
·
Alex Keown
Study Raises Concern Over Risk of Bias in EMA-Approved Cancer Trials

A new study shows that approximately half of clinical trials that supported approvals for new cancer drugs in Europe were judged to be at high risk of bias, meaning that some treatment effects might have been exaggerated.

September 19, 2019
·
3 min read
·
Alex Keown
Career Advice

How to Relocate for Your Life Sciences Career

Here are the keys to a smooth long distance job search. Follow these simple guidelines to avoid many of the stresses of job hunting from a distance.

September 19, 2019
·
3 min read
·
Katharine Hansen, PhD
Lone Star Bio

Castle Biosciences Added to Membership of US Small-Cap Russell 2000® Index

The stock also was automatically added to the appropriate growth and value indexes.

September 19, 2019
·
4 min read